Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. Pathology / 病理學科所
  4. Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer
 
  • Details

Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer

Journal
Radiation Oncology
Journal Volume
13
Journal Issue
1
Pages
157
Date Issued
2018
Author(s)
WAN-YU CHEN  
CHEN-TU WU  
CHUN-WEI WANG  
KENG-HSUEH LAN  
HSIANG-KUANG LIANG  
Huang B.-S.
YIH-LEONG CHANG  
SUNG-HSIN KUO  
ANN-LII CHENG  
DOI
10.1186/s13014-018-1099-6
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052504982&doi=10.1186%2fs13014-018-1099-6&partnerID=40&md5=7d6ed8d4a4891a67d19418f84a979d79
https://scholars.lib.ntu.edu.tw/handle/123456789/473735
Abstract
Background: Our aim was to investigate the prognostic significance of tumor-infiltrating lymphocytes (TILs) in operable tongue cancer patients. Methods: The presence of CD3 + , CD4 + , CD8 + , and forkhead box protein P3-positive (FOXP3 + ) TILs in tumor tissues obtained from 93 patients during surgery was examined using immunohistochemistry. Results: The 3-year overall survival (OS) of patients with a low CD8/FOXP3 ratio was significantly lower than that of patients with a high CD8/FOXP3 ratio (63.8% vs. 87.3%, p=0.001). Patients with high FOXP3 had a significantly lower 3-year regional recurrence-free survival (RRFS) than did patients with low FOXP3 (49.3% vs. 87.3%, univariate log rank p=0.000). A low CD4/FOXP3 ratio (68.4% vs. 93.7%, univariate log rank p=0.002) was significantly unfavorable prognostic factors for 3-year distant metastasis-free survival (DMFS). Conclusions: In addition to clinicopathological characteristics, TIL markers represent prognosticators for clinical outcomes. ? 2018 The Author(s).
SDGs

[SDGs]SDG3

Other Subjects
antineoplastic agent; CD3 antigen; CD4 antigen; CD8 antigen; transcription factor FOXP3; CD3 antigen; forkhead transcription factor; FOXP3 protein, human; adult; aged; Article; cancer patient; cancer prognosis; cancer radiotherapy; cancer surgery; cancer survival; cancer tissue; CD3+ tumor infiltrating lymphocyte; CD4+ tumor infiltrating lymphocyte; CD8+ tumor infiltrating lymphocyte; controlled study; diagnostic test accuracy study; distant metastasis free survival; female; forkhead box protein P3 positive tumor infiltrating lymphocyte; human; human cell; human tissue; immunohistochemistry; major clinical study; male; oral surgery; overall survival; recurrence free survival; reference value; survival time; tongue cancer; tumor associated leukocyte; CD4+ T lymphocyte; CD8+ T lymphocyte; chemistry; mortality; pathology; prognosis; Taiwan; tongue tumor; tumor recurrence; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Forkhead Transcription Factors; Humans; Immunohistochemistry; Lymphocytes, Tumor-Infiltrating; Male; Neoplasm Recurrence, Local; Prognosis; Taiwan; Tongue Neoplasms
Publisher
BioMed Central Ltd.
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science